Veterans make excellent employees. Yet over 18 percent of military veterans are 'functionally unemployed,' according to new ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will present five abstracts at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting taking place November 19-23 in Honolulu ...

The Novel Allosteric NEK7 Inhibitor Ofirnoflast (HT-6184) Demonstrates Robust and Sustained Hematologic Response in Subjects with IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndrome ...

In other words, we can use AI as a simulated audience: a stand-in that reacts to a data story as if it were a specific type ...

Harrison Barnes employs his own year-round strength coach and has a personal team of video analysts who provide him with ...

A quality improvement program helped reduce "bad cholesterol" (LDL or low-density lipoprotein) levels among military veterans ...

Three-year follow-up data from FIREFLY-1 demonstrates durable responses with evidence of clinical stability off treatment, with the potential for retreatment after progression Treatment-free interval ...

The integration of artificial intelligence (AI) into robotics is no longer a futuristic concept but a present-day reality poised for significant market expansion, according to global technology ...

Ethical guardrails ensure that innovation serves humanity, not just profit or convenience. Transparency, accountability, and ...

Alliance connects Danfoss drives’ technology with Honeywell Experion PKS to deliver new levels of energy savings, reliability ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced publication in The ...

Altimmune (ALT) announced publication in The Lancet of 24-week efficacy and safety data from the ongoing IMPACT Phase 2b trial of pemvidutide in ...